Build it yourself or, license a proven platform?
A decision framework for medical device and IVD manufacturers evaluating eIFU systems.
Most Build vs. Buy conversations underestimate the lifecycle cost by 3 to 5 times. This is the framework manufacturers actually need.
In short
For most medical device and IVD manufacturers, buying an eIFU platform is the lower-risk decision: it is typically 3 to 5 times cheaper over five years, goes live in 4 to 8 weeks instead of 12 to 24 months, and keeps regulatory coverage current. Building is only justifiable with mature regulatory IT and a permanent sustaining budget.
It is a lifecycle question, not an engineering one.
Can your team validate this to GxP/CSV? Sustain that state across releases? Operate global 24/7 paper-on-request? Keep pace with regulators in every jurisdiction?
Most in-house builds underestimate total lifecycle effort by three to five times.
Five dimensions where buying wins
Buying costs 3 to 5 times less over a 5-year horizon.
Live in 4 to 8 weeks, not 12 to 24 months.
MDR, IVDR, FDA, and 6 more. Kept current automatically.
Saves $150k–$400k of internal security build cost.
Roadmap evolves with regulations. Internal builds lag by year 4.
Which manufacturer profile fits you?
Profile A
BUY- Tight regulatory timeline
- Global distribution
- Lean internal IT
Build is not viable. Buy is the default.
Profile B
BUILD IS VIABLE- Mature regulatory IT
- Stable product portfolio
- Strategic mandate for digital labeling
Build is justifiable with permanent sustaining investment.
Profile C
BUY- Mid-size manufacturer
- Moderate IT capability
- Growing in regulated jurisdictions
Build is high-risk. Buy is materially lower-risk.
The majority of manufacturers fit Profile A or Profile C.
Common questions about build versus buy
Should you build or buy an eIFU platform?
Buy, unless you have mature regulatory IT capability, a stable product portfolio, and a standing budget to sustain the system for its whole lifecycle. The decision is not about whether an eIFU website can be built, but about who maintains validation, translations, security, and regulatory change monitoring for the next ten years.
What does it really cost to build an eIFU platform in-house?
The build itself is the smaller cost. Sustaining engineering, validation and revalidation, ISO 27001 aligned security work, penetration testing, hosting, paper copy fulfillment, and regulatory monitoring continue every year. Over a five-year horizon an in-house build typically costs three to five times more than buying.
How long does an in-house eIFU build take?
Internal builds commonly take 12 to 24 months to reach a validated, market-ready state, against 4 to 8 weeks for a pre-configured platform. That difference matters when a regulatory deadline or a market launch is driving the project.
When is building an eIFU platform actually the right call?
When regulatory IT is already a core internal competence, the portfolio is stable, digital labelling is a strategic mandate, and leadership commits permanent funding to sustain the system. Without that permanent sustaining investment, internal builds tend to stagnate from around year four.
What is the fastest way to decide?
Take the 2-minute self-assessment on this page. It scores your regulatory timeline, market footprint, internal IT capability, and portfolio stability, and returns a build or buy verdict with the reasoning behind it.